Articles
Clinuvel enters dermatology drug JV
Clinuvel (ASX:CUV) will form a joint venture with Biotech Lab Singapore to develop paediatric versions of Scenesse and a new dermatology drug candidate.
[ + ]Tracing the ancient ancestors of Europeans
An international team of researchers has compared ancient European hunter-gatherers and early farmers to present-day humans and found that modern Europeans can trace their ancestry to three ancient populations. [ + ]
Life Sciences = Future. Jobs. Exports.
Has the Australian biotech sector the potential to fill some of the gaps left by the demise of traditional manufacturing areas? Find out at AusBiotech 2014.
[ + ]R&D Tax Incentive - overseas R&D activities update
An update for companies on what "not available in Australia" means for meeting the requirements to make a claim for R&D activities conducted outside of Australia. [ + ]
Simavita's US partner wins first big contract
Simavita's (ASX:SVA) exclusive US distribution partner Medline has picked up its first major supply contract for the Smart Incontinence Management (SIM) medical device. [ + ]
GTG restructures to focus on molecular diagnosis
Genetic Technologies (ASX:GTG) has announced a restructuring project, as well as plans to launch the upgraded version of breast cancer risk test BREVAGen next month. [ + ]
Calzada, pSivida, GI Dynamics announce board moves
Calzada (ASX:CZD) has announced the resignation of an independent director, while GI Dynamics (ASX:GID) and pSivida (ASX:PVA) have selected new members for their own boards. [ + ]
2014 Eureka Prizes announced
The Australian Museum Eureka Prizes last night celebrated 25 years of rewarding outstanding contributions to Australian science. [ + ]
Clean tech lab to make products "benign by design"
In November 2013, Flinders University officially opened its Clean Technology Laboratory - a $1.1 million initiative to research and develop sustainable manufacturing methods. [ + ]
Invion ready to escalate dose in lupus trial
Analysis of safety data from the first two cohorts involved in Invion's (ASX:IVX) trial of INV103 in lupus has given the company the confidence to step up the dose for the next stage. [ + ]
Micropumps for lab-on-a-chip disease diagnosis
Researchers from Pennsylvania State University have demonstrated an acoustofluidic pump powered by a piezoelectric transducer the size of a coin. [ + ]
Rapid malaria detection with just a drop of blood
Singaporean scientists have invented a technique to detect malaria within minutes from a single drop of blood. The method was developed by the Singapore-MIT Alliance for Research and Technology (SMART) in collaboration with Nanyang Technological University (NTU).
[ + ]Viralytics CEO, biotech veteran join company board
Former CSL (ASX:CSL) executive Peter Turvey has been named a Viralytics (ASX:VLA) non-executive director, while Viralytics CEO Malcolm McColl will take the role of managing director. [ + ]
ResMed settles dispute with APEX Medical
ResMed (ASX:RMD) has declared a truce in its copyright infringement war with Taiwan's APEX Medical, signing a confidential settlement. [ + ]
Phylogica, IMB get $500K grant for cancer drug project
Phylogica and the UQ's Institute for Molecular Bioscience have picked up grant funding for a project to screen for potential new antimetastatic drugs. [ + ]